TELA Bio, Inc.
- CIK: 0001561921
- EIN: 45-5320061
- Business address: 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, Pennsylvania, 19355
Information
Mailing address
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, Delaware, 19355Phone
484-320-2930State location
PennsylvaniaState of incorporation
DelawareFiscal year end
December 31SIC
3841 - (CF Office: Office of Life Sciences) SURGICAL & MEDICAL INSTRUMENTS & APPARATUSFilings
N/A
About TELA Bio, Inc.
TELA Bio, Inc. (CIK: 0001561921) is an American company incorporated in the state of Pennsylvania. Head office is located at 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, Pennsylvania, 19355. Work in the industry 3841 - (CF Office: Office of Life Sciences) SURGICAL & MEDICAL INSTRUMENTS & APPARATUS. TELA Bio, Inc. is a public company and trade via Over-The-Counter (OTC).Ownership
| Owner | Filings | Transaction Date | Type of Owner |
|---|---|---|---|
| Firestone Gregory A. | 0001984584 | Aug-03-2023 | officer: Chief Business Officer |
| ORBIMED ADVISORS LLC | 0001055951 | Apr-19-2023 | 10 percent owner |
| OrbiMed Capital GP IV LLC | 0001502240 | Apr-19-2023 | 10 percent owner |
| Opaleye Management Inc. | 0001595855 | Jun-10-2022 | 10 percent owner |
| Quaker BioVentures II LP | 0001497725 | Jun-02-2022 | 10 percent owner |
| Quaker BioVentures Capital II, L.P. | 0001583083 | Jun-02-2022 | 10 percent owner |
| O'Brien Federica F. | 0001140119 | Jun-01-2022 | director |
| COLLERAN LISA N | 0001212312 | Jun-01-2022 | director |
| EVANS DOUGLAS G | 0001225164 | Jun-01-2022 | director |
| Burgess Vincent J | 0001365408 | Jun-01-2022 | director |
| Azarbarzin Kurt | 0001792303 | Jun-01-2022 | director |
| Nosenzo John | 0001835973 | Jun-01-2022 | director |
| KOBLISH ANTONY | 0001195881 | Feb-24-2022 | director, officer: Chief Executive Officer |
| Cuca Roberto | 0001591474 | Feb-23-2022 | officer: COO and CFO |
| Greenhalgh Ellis Skott | 0001790671 | Feb-23-2022 | officer: Chief Technology Officer |
| Murphy Peter C. | 0001801542 | Feb-23-2022 | officer: Chief Commercial Officer |
| Talmo Paul | 0001899089 | Jan-01-2022 | officer: Chief Strategic Officer |
| Smeykal Megan | 0001899973 | Jan-01-2022 | officer: Chief Accounting Officer, other: Controller |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | 0001746777 | Dec-31-2020 | other: See footnotes 1 and 2 |
| EW HEALTHCARE PARTNERS FUND 2-A, L.P. | 0001746779 | Dec-31-2020 | other: See footnotes 1 and 2 |
| EW Healthcare Partners Fund 2 GP, L.P. | 0001793943 | Dec-31-2020 | 10 percent owner |
| EW Healthcare Partners Fund 2-UGP, L.P. | 0001793948 | Dec-31-2020 | 10 percent owner |
| RTW INVESTMENTS, LP | 0001493215 | Dec-11-2019 | 10 percent owner |
| WONG RODERICK | 0001493280 | Dec-11-2019 | 10 percent owner |
| PERSENAIRE MAARTEN | 0001207313 | Nov-13-2019 | officer: Chief Medical Officer |
| Pacira BioSciences, Inc. | 0001396814 | Nov-13-2019 | director, 10 percent owner |
| Friedman Ashley | 0001790193 | Nov-13-2019 | director |
| Brennan Nora | 0001790215 | Nov-13-2019 | officer: Chief Financial Officer |
| Ellis Ronald J. Jr. | 0001790670 | Nov-13-2019 | director, 10 percent owner |
| Oliva Adele C | 0001339379 | Nov-08-2019 | director, 10 percent owner |
| Zuga Matt | 0001790214 | Nov-08-2019 | director |
Stock Chart
Coming soon!
Jobs
Coming soon!
Recent SEC Filings
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by TELA Bio, Inc.
| Filings | Format | Description | Filed/Effective | File/Film Number |
|---|---|---|---|---|
| SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000935836-24-000490 (34 Act) Size: 29 KB |
Jul-22-2024 | 241131353 |
| SC 13D/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000947871-24-000584 (34 Act) Size: 89 KB |
Jul-02-2024 | 241096633 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000947871-24-000583 ( Act) Size: 11 KB |
Jul-02-2024 | |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0000947871-24-000581 (33 Act) Size: 5 KB |
Jun-28-2024 | 241087127 |
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001839882-24-018369 (34 Act) Size: 125 KB |
Jun-10-2024 | 241031562 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001062993-24-012092 ( Act) Size: 7 KB |
Jun-06-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001062993-24-012091 ( Act) Size: 7 KB |
Jun-06-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001062993-24-012090 ( Act) Size: 7 KB |
Jun-06-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001062993-24-012089 ( Act) Size: 7 KB |
Jun-06-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001062993-24-012088 ( Act) Size: 7 KB |
Jun-06-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001062993-24-012081 ( Act) Size: 6 KB |
Jun-06-2024 | |
| 3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001062993-24-012080 ( Act) Size: 5 KB |
Jun-06-2024 | |
| 8-K | Document | Current report filing Acc-no: 0001104659-24-069099 (34 Act) Size: 237 KB |
Jun-06-2024 | 241025254 |
| 8-K | Document | Current report filing Acc-no: 0001104659-24-063416 (34 Act) Size: 226 KB |
May-20-2024 | 24964662 |
| 10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001558370-24-007784 (34 Act) Size: 4447 KB |
May-10-2024 | 24934806 |
| 8-K | Document | Current report filing Acc-no: 0001104659-24-059355 (34 Act) Size: 4439 KB |
May-09-2024 | 24931029 |
| ARS | Document | Annual report to security holders Acc-no: 0001104659-24-048842 (34 Act) Size: 2215 KB |
Apr-18-2024 | 24854385 |
| DEFA14A | Document | Additional definitive proxy solicitation materials Acc-no: 0001104659-24-048839 (34 Act) Size: 503 KB |
Apr-18-2024 | 24854367 |
| DEF 14A | Document | Definitive proxy statements Acc-no: 0001104659-24-048835 (34 Act) Size: 1777 KB |
Apr-18-2024 | 24854347 |
| 8-K | Document | Current report filing Acc-no: 0001104659-24-046970 (34 Act) Size: 223 KB |
Apr-15-2024 | 24843095 |
Recent 20 filings. View all TELA Bio, Inc. filings
Reviews
Jean Bishop
Very good communication and delivery made within the timeframe I was advised of
Catherine
Thanks I look forward to using the product to improve my skin tone
Samuel Ejimofor
It's being easier working on the website. And I recommend, it's a great website
Frequently Asked Questions
Tags:
- TELA Bio, Inc. overview
- TELA Bio, Inc. job
- TELA Bio, Inc. stock
- TELA Bio, Inc. ownership
- TELA Bio, Inc. CEO
- TELA Bio, Inc. documents
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
Orther Companies
Breathe BioMedical Inc.
Update: Jun 08, 2024
Aja Holdco, Inc.
Update: Mar 26, 2024
Solventum Corp
Update: Feb 21, 2024
WORK Medical Technology Group LTD
Update: Apr 28, 2023
MED EIBY Holding Co., Ltd
Update: Feb 25, 2023
Latest News
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Charges Crypto Company SafeMoon and its Executive Team for...
© 2022 